Literature DB >> 35771383

Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research.

Peiyu Huang1, Minming Zhang2.   

Abstract

Neurodegenerative diseases (NDs) have become a significant threat to an aging human society. Numerous studies have been conducted in the past decades to clarify their pathologic mechanisms and search for reliable biomarkers. Magnetic resonance imaging (MRI) is a powerful tool for investigating structural and functional brain alterations in NDs. With the advantages of being non-invasive and non-radioactive, it has been frequently used in both animal research and large-scale clinical investigations. MRI may serve as a bridge connecting micro- and macro-level analysis and promoting bench-to-bed translational research. Nevertheless, due to the abundance and complexity of MRI techniques, exploiting their potential is not always straightforward. This review aims to briefly introduce research progress in clinical imaging studies and discuss possible strategies for applying MRI in translational ND research.
© 2022. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.

Entities:  

Keywords:  Alzheimer's disease; Magnetic resonance imaging; Neurodegenerative disease; Parkinson's disease; Translational research

Year:  2022        PMID: 35771383     DOI: 10.1007/s12264-022-00905-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  146 in total

Review 1.  Biomarkers for neurodegenerative diseases.

Authors:  Oskar Hansson
Journal:  Nat Med       Date:  2021-06-03       Impact factor: 53.440

2.  Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future.

Authors:  Anthony E Lang
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

3.  The cost of Alzheimer's disease in China and re-estimation of costs worldwide.

Authors:  Jianping Jia; Cuibai Wei; Shuoqi Chen; Fangyu Li; Yi Tang; Wei Qin; Lina Zhao; Hongmei Jin; Hui Xu; Fen Wang; Aihong Zhou; Xiumei Zuo; Liyong Wu; Ying Han; Yue Han; Liyuan Huang; Qi Wang; Dan Li; Changbiao Chu; Lu Shi; Min Gong; Yifeng Du; Jiewen Zhang; Junjian Zhang; Chunkui Zhou; Jihui Lv; Yang Lv; Haiqun Xie; Yong Ji; Fang Li; Enyan Yu; Benyan Luo; Yanjiang Wang; Shanshan Yang; Qiumin Qu; Qihao Guo; Furu Liang; Jintao Zhang; Lan Tan; Lu Shen; Kunnan Zhang; Jinbiao Zhang; Dantao Peng; Muni Tang; Peiyuan Lv; Boyan Fang; Lan Chu; Longfei Jia; Serge Gauthier
Journal:  Alzheimers Dement       Date:  2018-02-09       Impact factor: 21.566

4.  Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases.

Authors:  Alexander Drzezga; Henryk Barthel; Satoshi Minoshima; Osama Sabri
Journal:  J Nucl Med       Date:  2014-05-12       Impact factor: 10.057

5.  Trajectories of imaging markers in brain aging: the Rotterdam Study.

Authors:  Elisabeth J Vinke; Marius de Groot; Vikram Venkatraghavan; Stefan Klein; Wiro J Niessen; M Arfan Ikram; Meike W Vernooij
Journal:  Neurobiol Aging       Date:  2018-07-17       Impact factor: 4.673

Review 6.  A hundred years of Alzheimer's disease research.

Authors:  John Hardy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

7.  Neuronal activity enhances tau propagation and tau pathology in vivo.

Authors:  Jessica W Wu; S Abid Hussaini; Isle M Bastille; Gustavo A Rodriguez; Ana Mrejeru; Kelly Rilett; David W Sanders; Casey Cook; Hongjun Fu; Rick A C M Boonen; Mathieu Herman; Eden Nahmani; Sheina Emrani; Y Helen Figueroa; Marc I Diamond; Catherine L Clelland; Selina Wray; Karen E Duff
Journal:  Nat Neurosci       Date:  2016-06-20       Impact factor: 24.884

8.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

9.  Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals.

Authors:  Heidi I L Jacobs; Trey Hedden; Aaron P Schultz; Jorge Sepulcre; Rodrigo D Perea; Rebecca E Amariglio; Kathryn V Papp; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  Nat Neurosci       Date:  2018-02-05       Impact factor: 24.884

10.  Current and projected future economic burden of Parkinson's disease in the U.S.

Authors:  Wenya Yang; Jamie L Hamilton; Catherine Kopil; James C Beck; Caroline M Tanner; Roger L Albin; E Ray Dorsey; Nabila Dahodwala; Inna Cintina; Paul Hogan; Ted Thompson
Journal:  NPJ Parkinsons Dis       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.